Member Info for Notposting

WTAF. LOL. Your posts continue to be as deluded as they’ve been misleading. For the record, again, I’ve never held UKOG, never will, and frankly, no one with any sense would go all in on a single stock. That’s your naive method, not mine. I don’t need to sell any share to buy another, nor do I engage in ramping or de‑ramping, unlike you. Keep trying, but you’ll never get it right, especially since I don’t juggle multiple aliases like you and “JustHereForFleecing.” 😘

The comedy value is brilliant.

Shicky. I’ve been pretty clear. I have no interest in doing ground work for you whilst you continue to feed a narrative. You can use it to play your cards 🫠 makes no odds to me.

Pingu. And how has ignoring facts and instead taking your advice/ trusting your misleading information worked out for those around you who didn’t have the luxury of selling and sitting on risk-free warrants?

🤯 doesn’t even understand what he’s talking about or the comparison 😆

This is why, Shicky, your approach consistently comes across as disingenuous, and this interaction reflects poorly on your integrity. You continue to make assertions without evidence, and you repeatedly claim I have not provided examples when I have always supported my points with information.

You may continue as you wish, but I will not waste further time engaging with someone who shows so little regard for accuracy or accountability. It is worth noting that you are the one who has topped up at premiums more than 100 per cent above today’s value and watched your investment decline, not me. That alone should indicate who has exercised better judgement.

Nothing is happening with ASH. It was unreasonable for the rampers to suggest otherwise, given the limited data available to them and where their immediate focus is likely to be during this critical period.

This is simply incorrect and demonstrates a lack of understanding. Your repeated, unfounded narratives are causing harm. There is no evidence to support your statements, nor is it plausible. Once again, you are misleading others rather than taking responsibility for your repeated behaviour, inappropriate conduct, and wrongful accusations.

You owe an apology to those who have naively followed your guidance and lost the opportunity to access critical funds. This behaviour must stop, as it is causing real damage while you benefit personally time and time again.

Shicky.

I highlighted the key points while also providing a link to the prospectus for visibility, which is not something you would do if you were attempting to cherry-pick information or mislead. Perhaps you are being naive, but the sale of a part is clearly not the preferred option; it is a last resort and therefore unlikely to be favourable. Despite this, some continue to suggest that an offer is forthcoming. The prospectus makes this clear and also explains that while the company would endeavour to secure a partial sale or offer for a candidate, it is by no means guaranteed. My point is related to the need for funding; I do not need to “cherry pick” to make that clear, as I have shared the relevant sections. Equally, I could highlight the less favourable parts as well, if required.

They have also repeatedly argued and presented the misleading view that funding would not be required and that there would be no delays due to the transfer. Both claims have been proven inaccurate.

Everyone should be reading the prospectus in full and focusing on key funding and operational issues. Comments that disregard this demonstrate a lack of ownership.

Additionally, the rampers highlighted only a select part of the prospectus, which created the misleading impression that a sale was the preferred funding option. This is not the case, as there is insufficient data to extract the value the company would likely require.

On your latter question. The remaining £1.1m would go towards the Made transfer and after that they would have no funds as such (subject to any further excercise) to progress the trials. I would suggest you take time to read the prospectus as that outlines the funds and issues clearly.

Shicky. Speaking of misleading, they do not have £2 million, as has been repeatedly pointed out to you and of which you are fully aware. Yet you continue to give a misleading impression and urgently require £5.6 million to continue the trials. This funding will not come from thin air and will likely be dilutive.

You present this as a fact, “there is no upcoming placing,” yet the company prospectus clearly indicates otherwise.

Shicky. I have never misled anyone; that is an objective fact. What concerns me is that, despite being repeatedly shown to be incorrect, you continue to promote a narrative that has no basis in reality. In the end, that reveals far more about your character than anything else. It is regrettable, though hardly unexpected, given that your group’s rhetoric has already cost good people life-changing sums. The real tragedy is that, even in the face of those consequences, you still appear unable to demonstrate even a basic sense of integrity.

Your previous post is a solid example. You’ve never proven any comment I’ve made to be false. Fact.

Good luck, Max. Hopefully long term it serves you well.

I guess as soon as funding is resolved it should see you well. That’s the bottom line and the reason for the market demonstrating concern.

Shicky. You’ve never once demonstrated I’ve ever made anything up. Fact.

You continue to be abusive, manipulative and wrong time and time again and post falsehoods repeatedly.

How does anyone still take JustHereForFleecing seriously? He is an amateur trader who clearly has no grasp of what he is talking about. His repeated misinformation has stopped good people from taking profits whilst taking his own, and even now he carries on as if nothing happened.

If he were truly as confident as he claims in his little echo chamber, he would have had a spread-bet long open a long time ago. But of course he does not, because he is making it up as he goes along.

The reality is simple: the company needs around £5.6m by January just to keep going.

So what happens?

Either the so-called “LTHs” dump their shares yet again on the market and then pretend to fund at a premium yet again to fleece another round of warrants, or Vlad turns to CLNs. And the lower the share price gets as we approach that funding crunch, the worse the terms become.

Meanwhile, “LTHs” are quietly selling, claims continue that warrants will not be exercised, CLNs will not be taken up, and yet he is still pushing the same narrative or shorters and traders with no shame.

“I know 50% of all shareholders.” “These are high net worth individuals.” “We saved the company” “no funding is needed” “No placing will take place” “PeterHouse specials are done” All nonsense to suit a narrative. They sell their holding and fund, not existing reserves overall. The price movement tells you that.

It is genuinely laughable. People need to start seeing these lot for what they are. Out for themselves at your cost. They’ll have sold at multiples whilst stringing you along. No morals. Lie after lie after lie and under multiple aliases.

Leave the echo chamber WhatsApp groups and do your own research. Do not trust these lot. They feed narratives about those that post sense to discredit, but the share price confirms who is worth listening to and who is not.

Of course they’ll spin the narrative if/ hopefully eventual success happens, but forget that the current posts are about the now not the future.

You should never ignore a stark warning from the actual business when it comes to funding. It’s key to any business.

😆😆😆😆😆

Was that ASH submission that all the rampers were hyping? The same thing that supposedly scared anyone making valid points (shorters) and were “sheeting” their pants over? Even though I said no one was actually worried about it when you have funding to worry about? Or given it was unlikely given the lack of data? 🫠

Wasn’t that supposed to allegedly ‘burn all the shorters?’ 😆

The rampers will sadly use patients to gaslight.

If they truly cared, they would be donating to a charity rather than fleecing the company with warrants or hyping things to profit from it. It is a sad world driven by greed.

Are* inseparable

“They’ve already lost on the science.”

In reality, no one is losing anything except those that are in the echo chamber of selfish individuals who would eat them as a starter, and no one wishes ill on the science, except in the narrative you have created just because someone challenges the mindless ramps.

The science has not yet proven anything, so even if a loss were possible, on what basis could you make such a claim?

They do not have enough data to secure funding that will likely be in favour, and they need funding to obtain that data. The two aren’t inseparable but having a coherent funding plan is an essential part of the business model, not a convenient afterthought nor should it be for those who pretend to champion the science while quietly lining their own pockets with utter nonsense.

The only thing tick tocking is funding, once again.

Or read what matters https://hemogenyx.com/wp-content/uploads/2025/11/Hemogenyx-Pharmaceuticals-plc-Prospectus-20251119.pdf

Read the official prospectus pointing out the following…

Don't forget they may need manufacturing runs too and in my opinion it’s unlikely you see the next treatment till late Q1/ early Q2 but it’s unknown at this stage as to where they are with that so granted could be earlier.

To address this anticipated funding shortfall, the Group will require ADDITIONAL WORKING CAPITAL OF £5.6 MILLION BY THE END OF JANUARY 2026 just to continue its product development activities with a primary focus on HG-CT-1 through to the end of 2026. A FURTHER £10 MILLION will be required from 2027 to 2028.

The Group will have INSUFFICIENT WORKING CAPITAL AFTER ADMISSION and further funds WILL BE REQUIRED in the first quarter of 2026 simply to continue operations and complete Phase I trials of HG-CT-1 in adult and paediatric patients.

The Company states clearly that working capital will be INSUFFICIENT FOR ITS PRESENT REQUIREMENTS for at least the next 12 months. Following Admission, Directors expect an AGGREGATE FUNDING SHORTFALL OF £15.6 MILLION.